By Verdict Medical Devices
Medical Marijuana has announced that its investment company AXIM Biotechnologies has developed a rapid diagnostic test that measures the levels of functional neutralising antibodies that are said to prevent SARS-CoV-2 (Covid-19) infection. AXIM’s test takes ten minutes and measures the certain subpopulation of antibodies to prevent the coronavirus from attacking the body. The company has submitted the application for pre-Emergency Use Authorisation (EUA) with the US Food and Drug Administration (FDA).

Read the Full Article